Report Detail
Global Pandemic Influenza Vaccine Market Insights, Forecast to 2025
- RnM2327884 |
- 27 May, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus.
The global Pandemic Influenza Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pandemic Influenza Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Pandemic Influenza Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pandemic Influenza Vaccine in these regions.
This research report categorizes the global Pandemic Influenza Vaccine market by top players/brands, region, type and end user. This report also studies the global Pandemic Influenza Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi
Valneva
Lupin
Chiron Panacea
Solvay and Serum Institute of India Pvt. Ltd.
Sementis
Market size by Product
Influenza A (H1N1) Vaccines
Other
Market size by End User
Adult
Paediatric
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Pandemic Influenza Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pandemic Influenza Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pandemic Influenza Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pandemic Influenza Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Pandemic Influenza Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pandemic Influenza Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Pandemic Influenza Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Product
- 1.4.2 Influenza A (H1N1) Vaccines
- 1.4.3 Other
- 1.5 Market by End User
- 1.5.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by End User
- 1.5.2 Adult
- 1.5.3 Paediatric
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pandemic Influenza Vaccine Market Size
- 2.1.1 Global Pandemic Influenza Vaccine Revenue 2014-2025
- 2.1.2 Global Pandemic Influenza Vaccine Sales 2014-2025
- 2.2 Pandemic Influenza Vaccine Growth Rate by Regions
- 2.2.1 Global Pandemic Influenza Vaccine Sales by Regions
- 2.2.2 Global Pandemic Influenza Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Pandemic Influenza Vaccine Sales by Manufacturers
- 3.1.1 Pandemic Influenza Vaccine Sales by Manufacturers
- 3.1.2 Pandemic Influenza Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Pandemic Influenza Vaccine Revenue by Manufacturers
- 3.2.1 Pandemic Influenza Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Pandemic Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Pandemic Influenza Vaccine Price by Manufacturers
- 3.4 Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pandemic Influenza Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Pandemic Influenza Vaccine Sales by Product
- 4.2 Global Pandemic Influenza Vaccine Revenue by Product
- 4.3 Pandemic Influenza Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Pandemic Influenza Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Pandemic Influenza Vaccine by Countries
- 6.1.1 North America Pandemic Influenza Vaccine Sales by Countries
- 6.1.2 North America Pandemic Influenza Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Pandemic Influenza Vaccine by Product
- 6.3 North America Pandemic Influenza Vaccine by End User
7 Europe
- 7.1 Europe Pandemic Influenza Vaccine by Countries
- 7.1.1 Europe Pandemic Influenza Vaccine Sales by Countries
- 7.1.2 Europe Pandemic Influenza Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pandemic Influenza Vaccine by Product
- 7.3 Europe Pandemic Influenza Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Pandemic Influenza Vaccine by Countries
- 8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Countries
- 8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Pandemic Influenza Vaccine by Product
- 8.3 Asia Pacific Pandemic Influenza Vaccine by End User
9 Central & South America
- 9.1 Central & South America Pandemic Influenza Vaccine by Countries
- 9.1.1 Central & South America Pandemic Influenza Vaccine Sales by Countries
- 9.1.2 Central & South America Pandemic Influenza Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Pandemic Influenza Vaccine by Product
- 9.3 Central & South America Pandemic Influenza Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Pandemic Influenza Vaccine by Countries
- 10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Pandemic Influenza Vaccine by Product
- 10.3 Middle East and Africa Pandemic Influenza Vaccine by End User
11 Company Profiles
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
- 11.1.5 AstraZeneca Recent Development
- 11.2 GlaxoSmithKline
- 11.2.1 GlaxoSmithKline Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GlaxoSmithKline Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered
- 11.2.5 GlaxoSmithKline Recent Development
- 11.3 Novartis
- 11.3.1 Novartis Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis Pandemic Influenza Vaccine Products Offered
- 11.3.5 Novartis Recent Development
- 11.4 Sanofi
- 11.4.1 Sanofi Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sanofi Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sanofi Pandemic Influenza Vaccine Products Offered
- 11.4.5 Sanofi Recent Development
- 11.5 Valneva
- 11.5.1 Valneva Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Valneva Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Valneva Pandemic Influenza Vaccine Products Offered
- 11.5.5 Valneva Recent Development
- 11.6 Lupin
- 11.6.1 Lupin Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Lupin Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Lupin Pandemic Influenza Vaccine Products Offered
- 11.6.5 Lupin Recent Development
- 11.7 Chiron Panacea
- 11.7.1 Chiron Panacea Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Chiron Panacea Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered
- 11.7.5 Chiron Panacea Recent Development
- 11.8 Solvay and Serum Institute of India Pvt. Ltd.
- 11.8.1 Solvay and Serum Institute of India Pvt. Ltd. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered
- 11.8.5 Solvay and Serum Institute of India Pvt. Ltd. Recent Development
- 11.9 Sementis
- 11.9.1 Sementis Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Sementis Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Sementis Pandemic Influenza Vaccine Products Offered
- 11.9.5 Sementis Recent Development
12 Future Forecast
- 12.1 Pandemic Influenza Vaccine Market Forecast by Regions
- 12.1.1 Global Pandemic Influenza Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Pandemic Influenza Vaccine Market Forecast by Product
- 12.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Pandemic Influenza Vaccine Market Forecast by End User
- 12.4 North America Pandemic Influenza Vaccine Forecast
- 12.5 Europe Pandemic Influenza Vaccine Forecast
- 12.6 Asia Pacific Pandemic Influenza Vaccine Forecast
- 12.7 Central & South America Pandemic Influenza Vaccine Forecast
- 12.8 Middle East and Africa Pandemic Influenza Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pandemic Influenza Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Pandemic Influenza Vaccine. Industry analysis & Market Report on Pandemic Influenza Vaccine is a syndicated market report, published as Global Pandemic Influenza Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Pandemic Influenza Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
